Sio Capital Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$697.3M
Q ending 2026-03-31
Prior quarter
$635.7M
Q ending 2025-12-31
Change
+9.7% QoQ · +107.7% YoY
Positions
76
reported holdings
Largest positions
All 76 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Maximus Inc | MMS | Shares | $49.3M | 769K |
| Waystar Hldg Corp | WAY | Shares | $39.6M | 1.6M |
| Icon Plc | Shares | $33.9M | 306K | |
| Cencora Inc | COR | Shares | $31.7M | 101K |
| Dianthus Therapeutics Inc | DNTH | Shares | $31.1M | 370K |
| Anteris Technologies Global | AVR | Shares | $29.9M | 5.4M |
| Corcept Therapeutics Inc | CORT | Shares | $27.2M | 675K |
| Livanova Plc | Shares | $26.8M | 422K | |
| Tyra Biosciences Inc | TYRA | Shares | $23.2M | 605K |
| Celcuity Inc | CELC | Shares | $22.1M | 194K |
| Gsk Plc | GSK | Shares | $21.3M | 386K |
| Ani Pharmaceuticals Inc | ANIP | Shares | $20.4M | 266K |
| Abbott Laboratories | ABT | Shares | $19.2M | 187K |
| Embecta Corp | EMBC | Shares | $16.3M | 1.8M |
| Abivax Sa | ABVX | Shares | $15.1M | 136K |
| Vir Biotechnology Inc | VIR | Shares | $13.4M | 1.5M |
| Haemonetics Corp Mass | HAE | Shares | $12.4M | 221K |
| Sionna Therapeutics Inc | SION | Shares | $11.8M | 294K |
| Sanofi Sa | SNY | Shares | $11.5M | 240K |
| Rapport Therapeutics Inc | RAPP | Shares | $11.5M | 367K |
| Teleflex Incorporated | TFX | Shares | $11.3M | 95K |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $11.0M | 194K |
| Cross Ctry Healthcare Inc | CCRN | Shares | $10.3M | 1.1M |
| Protara Therapeutics Inc | TARA | Shares | $10.3M | 2.0M |
| Structure Therapeutics Inc | GPCR | Shares | $10.1M | 209K |
| Biohaven Ltd | Shares | $9.8M | 1.2M | |
| Monopar Therapeutics Inc | MNPR | Shares | $9.5M | 174K |
| Eyepoint Inc | EYPT | Shares | $9.3M | 722K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $9.1M | 250K |
| Edgewise Therapeutics Inc | EWTX | Shares | $8.5M | 269K |
| Compass Pathways Plc | CMPS | Shares | $8.3M | 1.5M |
| Ocular Therapeutix Inc | OCUL | Shares | $8.2M | 969K |
| Aquestive Therapeutics Inc | AQST | Shares | $8.0M | 1.9M |
| Relmada Therapeutics Inc | RLMD | Shares | $6.7M | 965K |
| Oruka Therapeutics Inc | ORKA | Shares | $6.5M | 132K |
| Zenas Biopharma Inc | ZBIO | Shares | $6.5M | 332K |
| Bright Minds Biosciences Inc | DRUG | Shares | $6.3M | 86K |
| Quidelortho Corp | QDEL | Shares | $5.9M | 359K |
| Zimmer Biomet Holdings Inc | ZBH | Shares | $5.7M | 63K |
| Replimune Group Inc | REPL | Shares | $5.5M | 720K |
| Organon & Co | OGN | Shares | $5.2M | 866K |
| Onkure Therapeutics Inc | OKUR | Shares | $4.5M | 1.1M |
| Disc Medicine Inc | IRON | Shares | $4.2M | 65K |
| Pmv Pharmaceuticals Inc | PMVP | Shares | $3.8M | 3.1M |
| Immunome Inc | IMNM | Shares | $3.6M | 165K |
| Integra Lifesciences Hldgs C | IART | Shares | $3.6M | 383K |
| Savara Inc | SVRA | Shares | $3.4M | 614K |
| Centene Corp Del | CNC | Put | $3.3M | 100K |
| Proqr Therapeutics N V | Shares | $3.2M | 2.0M | |
| Shoulder Innovations Inc | SI | Shares | $3.1M | 211K |
| Ovid Therapeutics Inc | OVID | Shares | $2.8M | 1.3M |
| Kymera Therapeutics Inc | KYMR | Shares | $2.7M | 32K |
| Aligos Therapeutics Inc | ALGS | Shares | $2.4M | 327K |
| Context Therapeutics Inc | CNTX | Shares | $2.4M | 918K |
| An2 Therapeutics Inc | ANTX | Shares | $2.2M | 657K |
| Serina Therapeutics Inc | SER | Shares | $1.9M | 1.0M |
| Ibio Inc | IBIO | Shares | $1.7M | 904K |
| Adagio Med Hldgs Inc | ADGM | Shares | $1.5M | 1.3M |
| Xilio Therapeutics Inc | XLO | Shares | $1.3M | 152K |
| Bridgebio Oncology Therapeut | BBOT | Shares | $1.2M | 131K |
| Hyperfine Inc | HYPR | Shares | $1.1M | 1.0M |
| Senseonics Hldgs Inc | SENS | Shares | $771K | 116K |
| Foghorn Therapeutics Inc | FHTX | Shares | $587K | 123K |
| Terns Pharmaceuticals Inc | 430 | Shares | $532K | 10K |
| Enanta Pharmaceuticals Inc | ENTA | Shares | $505K | 40K |
| Tela Bio Inc | TELA | Shares | $395K | 636K |
| Neuroone Med Technologies Co | Shares | $386K | 497K | |
| Boundless Bio Inc | BOLD | Shares | $180K | 164K |
| Nyxoah S A | Shares | $148K | 51K | |
| Modular Med Inc | MODD | Shares | $138K | 26K |
| Elicio Therapeutics Inc | ELTX | Put | $125K | 12K |
| Erasca Inc | ERAS | Shares | $81K | 5K |
| Oscar Health Inc | OSCR | Put | $34K | 3K |
| Rocket Pharmaceuticals Inc | RCKTW | Shares | $7K | 400K |
| Humacyte Inc | HUMAW | Shares | $5K | 50K |
| Simulations Plus Inc | SLP | Shares | $2K | 200 |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.